Clinical Trials Directory

Trials / Unknown

UnknownNCT05105217

Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
85 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
16 Years – 70 Years
Healthy volunteers

Summary

1.Assessment of slit2 level in SLE patients and its correlation with disease activity. 2-Assessment of slit2 level in SSC patients and its correlation with disease activity

Detailed description

Systemic lupus erythematosus (SLE) is the most serologically and clinically diverse autoimmune disease. Immune dysregulation leads to excess production of autoantibodies and immune complexes. excess complement activation, and insidious tissue inflammation in patients with SLE. SLE is characterized by multisystem involvement commonly affecting the skin, renal, and musculoskeletal systems . Lupus nephritis is an important cause of both acute kidney injury and chronic kidney disease that can result in end-stage renal disease. Its pathogenic mechanisms are characterized by aberrant activation of both innate and adaptive immune responses, dysregulation of inflammatory signaling pathways, and increased cytokines production . Systemic sclerosis (SSC) is an autoimmune disease with characteristic vascular damage and fibrosis of the skin and internal organs. Diagnosis of SSC is mainly based on the clinical course and features in addition to laboratory findings including autoantibody profiles . Slit2, as a member of the Slit family, is secreted glycoprotein. Slit2 functions by binding to its transmembrane receptor Robo. Robo has four isoforms (Robo14). Slit2-Robo regulates cell functions, such as regulating leukocytes in chemotaxis and promoting endothelial cell migration and tube formation. Slit2 might promote the pathogenesis of LN by affecting various cell dysfunction in addition to leukocyte infiltration. In SSC, vascular involvement is a primary event characterized by vascular tone dysfunction and microcirculatory abnormalities. Many classes of guidance molecules, such as members of the secreted glycoproteins Slits and their Roundabout (Robo) receptors, play critical roles in angiogenesis. Among these, Robo1 and Robo4 are expressed in endothelial cells. .

Conditions

Interventions

TypeNameDescription
OTHERSlit2 biomarker1.Assessment of slit2 level in SLE patients and its correlation with disease activity. 2-Assessment of slit2 level in SSC patients and its correlation with disease activity

Timeline

Start date
2021-12-01
Primary completion
2022-12-01
Completion
2023-02-01
First posted
2021-11-03
Last updated
2021-11-03

Source: ClinicalTrials.gov record NCT05105217. Inclusion in this directory is not an endorsement.